A retrospective study to evaluate a prospective cohort of patients with melanoma who underwent clinical tumor sequencing using the MSK-IMPACT assay
Latest Information Update: 26 May 2022
At a glance
- Drugs Ipilimumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Bone metastases; Brain metastases; Cancer metastases; Liver metastases; Malignant melanoma
- Focus Pharmacodynamics; Therapeutic Use
- 13 Apr 2022 Results evaluating the impact of chromosomal instability on mucosal melanoma tumor infiltrate and responses to PD-1 based therapy presented at the 113th Annual Meeting of the American Association for Cancer Research
- 04 Feb 2021 New trial record
- 28 Jan 2021 Results published in the Clinical Cancer Research